Tickerplace logo

Tickerplace

Neuren Pharmaceuticals Limited logo

NEUNeuren Pharmaceuticals Limited

NEU Stock Price, Valuation & Chart | Neuren Pharmaceuticals Limited

Compare
$20.210+1.02 (+5.32%)

At close · 16 Oct 2026, 05:10 am

Sector: HealthcareIndustry: BiotechnologyWebsite
OverviewFinancialsDividendsRatios

NEU Historical price chart

NEU Key Stats

Market Capitalization2.56B
PE Ratio130.18
EPS0.16
Trading Volume276.96K
Today's High/Low20.21/19.39
Dividend Yield0.00
52 Week High/Low23.76/11.0
Shares Outstanding126.77M
NEU Financial Statement

NEU Analyst ratings

Buy

Strong buy
1
Buy
5
Hold
0
Sell
0
Strong sell
0

Based on 6 analysts giving stock ratings to NEU in the past 3 months.

NEU Analysis & performance metrics

NEU Company profile

Neuren Pharmaceuticals Limited, a biopharmaceutical company, develops drugs for the treatment of neurological disorders. Its lead product is trofinetide, which is in Phase…

NEU Management team

Management
Liza A. Squires M.D.
Chief Medical Officer
Gerry Zhao
Chief Business Officer
Lauren Frazer C.A.CFO
Chief Financial Officer & Company Secretary
Jonathan Charles Pilcher A.C.A., ACA, B.Sc., BSc (Hons), F.C.A.CEO
Chief Executive Officer, MD & Executive Director
Clive Blower BSc (Hons), Ph.D.
Chief Operations Officer
Lawrence Glass BA (Biology)
Chief Science Officer
Total 6 executives

NEU Frequently asked questions

What is Neuren Pharmaceuticals Limited (NEU) Stock Price?

Current stock price of Neuren Pharmaceuticals Limited (NEU) stock is $20.210. The stock price is +5.32% higher in the session. The intraday range can be seen from this page. Volume of Neuren Pharmaceuticals Limited (NEU) stock is 276.96K.

Last updated at 16 Oct 2026, 05:10 am.

Why is the Neuren Pharmaceuticals Limited (NEU) stock price going up or down today?

The stock price of Neuren Pharmaceuticals Limited (NEU) can change with earnings, company news, and overall market sentiment. Neuren Pharmaceuticals Limited operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Neuren Pharmaceuticals Limited stock expensive at its current price?

Whether Neuren Pharmaceuticals Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for NEU on this page is 130.18. EPS on this page is 0.16. Compare those figures with peers and growth expectations before deciding if the current Neuren Pharmaceuticals Limited price is justified.

How has the stock price of Neuren Pharmaceuticals Limited (NEU) performed historically?

Historical performance for Neuren Pharmaceuticals Limited (NEU) is shown on the price chart on this page. Review multi-period moves alongside volume to see how NEU reacted to past earnings and market events.

Should I buy Neuren Pharmaceuticals Limited (NEU) stock, at this price?

Buying Neuren Pharmaceuticals Limited (NEU) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.